CMEonHIV.com is dedicated to providing online CME presentations (slides with voiceover) on HIV/AIDS for healthcare professionals given by local and international experts to keep you up-to-date on the ongoing developments in the field.
Conference
"Internet-Based Post-Marketing Surveillance System for Patients with HIV/AIDS: a Pilot Project" Lizanne Béïque (biography) English - 2005-01-06 - 34 minutes
(26 slides)
Summary : The number of medications used in the treatment of HIV/AIDS is expanding rapidly. Effective methods for post-marketing surveillance are therefore increasingly important. Lizanne Béïque presents here the results of a pilot project for an internet-based post-marketing surveillance system that was sponsored by the Ontario HIV Treatment Network.
Because of the need to fast-track new HIV/AIDS drugs, there is often limited pre-marketing safety data for novel therapies. Adverse events are, as a result, not infrequently first encountered in the post-marketing period. Béïque and colleagues examined the feasibility and viability of developing and implementing a user-friendly adverse event reporting application for HIV/AIDS patients that could be accessed over the internet. How issues of security and patient acceptability were addressed is discussed. The benefit of such a system relative to the cost of maintaining and monitoring it is also examined in this presentation, as are the limitations of an internet-based reporting system.
This very interesting discussion of a new tool that may well become a mainstay of post-marketing surveillance in the 21st Century is certainly not to be missed.
Learning objectives : After viewing this presentation, participants will be able to discuss:
• The design and evaluation of an internet-based adverse event reporting application for HIV/AIDS patients
• The feasibility and viability, as well as the limitations of such a system
Bibliographic references : Reference of Interest:
Sheehan NL, Kelly DV, Tseng AL, van Heeswijk RP, Beique LC, Hughes CA; Canadian HIV/AIDS Pharmacists Network. Evaluation of HIV drug interaction web sites. Ann Pharmacother. 2003 Nov;37(11):1577-86.
USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.
